Cheng was born in 1986, and grew up in Shandong, China. He obtained his Master degree in Harbin Institute of Technology (HIT) in 2012. He started his PhD study from December in 2012 under the supervision of prof. Andrew Whittaker. His research interests are in the development of novel responsive MRI contrast agents for cancer diagnosis at early stage. The molecular level understanding of the ‘smart’ contrast agents were also investigated using high resolution NMR and molecular dynamics (MD) simulation studies. He has started his research study in Hawker group since October 2015 as a visiting researcher.